Companies / Castle Biosciences
Castle Biosciences
United States
Castle Biosciences develops and provides molecular prognostic and diagnostic tests for various diseases, including skin and eye cancers.
Castle Biosciences, based in United States, has 5 investors on file, among them BrightEdge, Gore Range Capital and Illumina Ventures. Its site was last checked 12 Nov 2026: site answers.
SEC Form D filings
6 filingsFiled by CASTLE BIOSCIENCES INC with the SEC. A Form D reports a private offering; it is not a priced round.
Investors
5 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Corporate VC | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
In the news
4 headlines naming Castle BiosciencesEach headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Castle Biosciences and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when BrightEdge adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/castlebiosciences.com/investors
# also
GET /v1/companies/castlebiosciences.com
GET /v1/companies/castlebiosciences.com/news